US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nurix Therapeutics

11.47

-0.0900-0.78%

Pre-market: 11.22-0.2500-2.18%08:02 EDT

Volume:784.36K

Turnover:8.96M

Market Cap:874.42M

PE:-4.09

High:11.72

Open:11.62

Low:11.25

Close:11.56

Loading ...

Overview Company News Filings

Leerink Partners Sticks to Its Hold Rating for Nurix Therapeutics (NRIX)

NRIX Stock Up as SNY In-Licenses Rights to Autoimmune Diseases Program

Truist Financial Sticks to Their Buy Rating for Nurix Therapeutics (NRIX)

Calendar of U.S. Earnings Expected in the Week Ahead

Nurix Therapeutics, Inc. (NRIX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Nurix Therapeutics Price Target Maintained With a $36.00/Share by HC Wainwright & Co.

BRIEF-Nurix Licenses A Drug Discovery Program To Sanofi Targeting A Novel Transcription Factor For Autoimmune Diseases

Nurix Therapeutics Signs Exclusive Licensing Deal With Sanofi for Autoimmune Disease Program

MT Newswires Live

Nurix Therapeutics in Expanded Collaboration with Sanofi

Nurix Therapeutics- Receives $15 Mln License Extension Fee From Sanofi

THOMSON REUTERS

Nurix Licenses a Drug Discovery Program to Sanofi Targeting a Novel Transcription Factor for Autoimmune Diseases

THOMSON REUTERS

Nurix Therapeutics- Eligible for Additional $465 Mln in Milestones and Royalties

THOMSON REUTERS

Nurix Licenses a Drug Discovery Program to Sanofi Targeting a Novel Transcription Factor for Autoimmune Diseases

BRIEF-Nurix Therapeutics Announces Multiple Presentations At The American Association For Cancer Research (AACR) 2025 Annual Meeting

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares May Have Slumped 25% But Getting In Cheap Is Still Unlikely

Simply Wall St.

Nurix Therapeutics Initiated at Market Perform by Leerink Partners

Nurix Gets FDA Orphan Designation for Bexobrutideg in Waldenstrom Macroglobulinemia

Nurix Therapeutics' Blood Cancer Drug Candidate Gets FDA Orphan Drug Designation

MT Newswires Live

Nurix Therapeutics Inc : Leerink Partners Initiates Coverage With Market Perform Rating; Price Target $16

THOMSON REUTERS

Nurix Announces U.S. FDA Orphan Drug Designation Granted to Bexobrutideg (Nx-5948) for the Treatment of WaldenstrÖM Macroglobulinemia

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NRIX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NRIX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRIX\",,,,,undefined,":{"symbol":"NRIX","market":"US","secType":"STK","nameCN":"Nurix Therapeutics","latestPrice":11.47,"timestamp":1745870400000,"preClose":11.56,"halted":0,"volume":784359,"hourTrading":{"tag":"盘前","latestPrice":11.22,"preClose":11.47,"latestTime":"08:02 EDT","volume":597,"amount":6777.109971,"timestamp":1745928153362},"delay":0,"floatShares":59121976,"shares":76235594,"eps":-2.805453,"marketStatus":"Pre-Mkt","change":-0.09,"latestTime":"04-29 09:11:34 EDT","open":11.62,"high":11.72,"low":11.25,"amount":8960852.137293,"amplitude":0.040657,"askPrice":18.35,"askSize":200,"bidPrice":11.1,"bidSize":2998,"shortable":3,"etf":0,"ttmEps":-2.805453,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745933400000},"marketStatusCode":1,"adr":0,"listingDate":1595563200000,"exchange":"NASDAQ","adjPreClose":11.47,"preHourTrading":{"tag":"盘前","latestPrice":11.22,"preClose":11.47,"latestTime":"08:02 EDT","volume":597,"amount":6777.109971,"timestamp":1745928153362},"postHourTrading":{"tag":"盘后","latestPrice":11.47,"preClose":11.47,"latestTime":"17:44 EDT","volume":258184,"amount":2961370.26,"timestamp":1745876657301},"volumeRatio":0.6122261171186661,"impliedVol":0.8523,"impliedVolPercentile":0.5622},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRIX\",,,,,undefined,":{"symbol":"NRIX","floatShares":59121976,"roa":"-31.08%","roe":"-64.16%","lyrEps":-2.883912,"volumeRatio":0.6122261171186661,"shares":76235594,"dividePrice":0,"high":11.72,"amplitude":0.040657,"preClose":11.56,"low":11.25,"week52Low":8.18,"pbRate":"1.82","psRate":"15.50","week52High":29.56,"institutionHeld":0,"latestPrice":11.47,"committee":0.874922,"eps":-2.805453,"divideRate":0,"volume":784359,"delay":0,"ttmEps":-2.805453,"open":11.62,"prevYearClose":18.84,"prevWeekClose":11.56,"prevMonthClose":11.88,"prevQuarterClose":11.88,"fiveDayClose":10.55,"twentyDayClose":12.15,"sixtyDayClose":20.015},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NRIX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524027823","title":"Leerink Partners Sticks to Its Hold Rating for Nurix Therapeutics (NRIX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524027823","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524027823?lang=en_us&edition=fundamental","pubTime":"2025-04-04 14:37","pubTimestamp":1743748672,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Faisal Khurshid reiterated a Hold rating on Nurix Therapeutics (NRIX – Research Report) on April 2. The company’s shares c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/leerink-partners-sticks-to-its-hold-rating-for-nurix-therapeutics-nrix?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/leerink-partners-sticks-to-its-hold-rating-for-nurix-therapeutics-nrix?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NRIX"],"gpt_icon":0},{"id":"2524419264","title":"NRIX Stock Up as SNY In-Licenses Rights to Autoimmune Diseases Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2524419264","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524419264?lang=en_us&edition=fundamental","pubTime":"2025-04-03 21:08","pubTimestamp":1743685680,"startTime":"0","endTime":"0","summary":"Nurix TherapeuticsNRIX shares rose 8.7% on Wednesday after the company announced that Sanofi SNY has in-licensed exclusive rights to an undisclosed Nurix program aimed at a previously untreatable transcription factor for autoimmune diseases. This undisclosed target plays a key role in regulating inflammation and is separate from the previously revealed STAT6 degrader program, signed between the companies in 2019. The stock is gaining further in the pre-market hours on Thursday.Nurix and Sanofi first established a strategic collaboration in 2019 to develop and commercialize a portfolio of targeted protein degradation therapies for patients with complex diseases across various therapeutic areas. The partnership utilizes NRIX’s proprietary DEL-AI discovery platform to discover small molecules that promote the degradation of three initially designated drug targets. In 2021, Sanofi exercised its option to expand the number of targets from three to five.The latest update further expands the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nrix-stock-sny-licenses-rights-130800564.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4585","SNY","LU1559883803.SGD","BAYRY","BK4139","LU0566484027.USD","NRIX","IE00BFXG1179.USD","BK4532","BK4588"],"gpt_icon":1},{"id":"2524541256","title":"Truist Financial Sticks to Their Buy Rating for Nurix Therapeutics (NRIX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524541256","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524541256?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:48","pubTimestamp":1743680887,"startTime":"0","endTime":"0","summary":"In a report released today, Srikripa Devarakonda from Truist Financial reiterated a Buy rating on Nurix Therapeutics (NRIX – Research Report). The ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/truist-financial-sticks-to-their-buy-rating-for-nurix-therapeutics-nrix-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/truist-financial-sticks-to-their-buy-rating-for-nurix-therapeutics-nrix-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NRIX"],"gpt_icon":0},{"id":"2524239365","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2524239365","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524239365?lang=en_us&edition=fundamental","pubTime":"2025-04-03 18:00","pubTimestamp":1743674400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·MSC Indus Dir.                                   2Q       .68   6:30 AM. ·Dave & Buster's Ent                             4Q       .69       AMC. ·Kura Sushi USA                                  2Q      (.10)  4:05 PM. ·RPM Intl Inc.                                    3Q       .51   6:45 AM. ·Delta Air Lines Inc.                             1Q       .44   6:30 AM. ·Simply Gd Foods                                 2Q       .40   7:00 AM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4096","BK4557","LU0757428866.USD","LU0203345920.USD","BK4152","BK4504","LAKE","AYI","BK4559","APOG","IE00B66KJ199.SGD","LU0128525689.USD","SMPL","MAMA","CARM","BK4139","KRUS","LU1267930227.SGD","LU0052756011.USD","TBBB","BK4113","BK4155","TLRY","PLAY","LU1815336091.USD","PSMT","MSM","DAL","NRIX","BK4585","LEVI","NEOG","RPM","LU2552382132.HKD","CAG","LW","BK4167","BK4568","STZ","LNN","SLP","AMC","RDUS","CALM","BK4202","BK4212","BK4086","LU0310800965.SGD","LU0203347892.USD","CRVO"],"gpt_icon":0},{"id":"2524551411","title":"Nurix Therapeutics, Inc. (NRIX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2524551411","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524551411?lang=en_us&edition=fundamental","pubTime":"2025-04-02 22:00","pubTimestamp":1743602404,"startTime":"0","endTime":"0","summary":"Wall Street expects a year-over-year increase in earnings on lower revenues when Nurix Therapeutics, Inc.  reports results for the quarter ended February 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.This company is expected to post quarterly loss of $0.74 per share in its upcoming report, which represents a year-over-year change of +2.6%.Revenues are expected to be $13.17 million, down 20.6% from the year-ago quart","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nurix-therapeutics-inc-nrix-may-140004711.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NRIX"],"gpt_icon":0},{"id":"2524493778","title":"Nurix Therapeutics Price Target Maintained With a $36.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2524493778","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524493778?lang=en_us&edition=fundamental","pubTime":"2025-04-02 20:54","pubTimestamp":1743598440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NRIX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 02, 2025 08:54 ET (12:54 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRIX"],"gpt_icon":0},{"id":"2524467402","title":"BRIEF-Nurix Licenses A Drug Discovery Program To Sanofi Targeting A Novel Transcription Factor For Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2524467402","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524467402?lang=en_us&edition=fundamental","pubTime":"2025-04-02 20:10","pubTimestamp":1743595844,"startTime":"0","endTime":"0","summary":"BRIEF-Nurix Licenses A Drug Discovery Program To Sanofi Targeting A Novel Transcription Factor For Autoimmune DiseasesApril 2  - Nurix Therapeutics Inc NRIX.O:NURIX LICENSES A DRUG DISCOVERY PROGRAM TO SANOFI TARGETING A NOVEL TRANSCRIPTION FACTOR FOR AUTOIMMUNE DISEASESNURIX THERAPEUTICS- RECEIVES $15 MILLION LICENSE EXTENSION FEE FROM SANOFINURIX THERAPEUTICS- ELIGIBLE FOR ADDITIONAL $465 MILLION IN MILESTONES AND ROYALTIESSource text: ID:nGNXp0z2Further company coverage: NRIX.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nFWN3QF1D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRIX"],"gpt_icon":0},{"id":"2524464194","title":"Nurix Therapeutics Signs Exclusive Licensing Deal With Sanofi for Autoimmune Disease Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2524464194","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524464194?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:46","pubTimestamp":1743594368,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics  said Wednesday that Sanofi  has exclusively licensed an undisclosed Nurix program targeting a previously undruggable transcription factor for autoimmune diseases.The company said the target is a key regulator of inflammation and is separate from its earlier disclosed STAT6 degrader program.Under the collaboration, Nurix said it will use its DEL-AI drug discovery platform to identify new agents that utilize E3 ligases to degrade the target.Sanofi has the right to license drug candidates resulting from the work, while Nurix has the option to co-develop and co-promote up to two products in the US after clinical proof of concept, it added.For programs where Nurix doesn't exercise its co-development option, it will receive milestones and royalties based on global sales, the company said.Nurix said it received a $15 million license extension fee from Sanofi under its 2019 collaboration agreement, bringing the total amount to date to $105 million, and is eligible for up to","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFXG1179.USD","BK4139","BK4588","SNYNF","NRIX","BK4007","SNY","BK4585"],"gpt_icon":0},{"id":"2524461423","title":"Nurix Therapeutics in Expanded Collaboration with Sanofi","url":"https://stock-news.laohu8.com/highlight/detail?id=2524461423","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524461423?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:33","pubTimestamp":1743593580,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics has widened its collaboration with Sanofi, granting the French pharmaceutical company an exclusive license to an undisclosed program targeting a previously undruggable transcription factor for autoimmune diseases.Nurix on Wednesday said it received a $15 million license extension fee from Sanofi under its 2019 collaboration agreement, bringing the total amount the San Francisco clinical-stage biopharmaceutical company has received to date under the pact to $105 million.Nurix said the new collaboration target is a central regulator of the inflammation response and is distinct from the companies' existing STAT6 degrader program.Nurix said it remains eligible for up to $465 million in development, regulatory and commercial milestone payments per licensed program under its work with Sanofi, as well as royalties on future sales.Shares of Nurix were recently up 3.1% to $10.79 in premarket trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE00BFXG1179.USD","SNYNF","SNY","NRIX","BK4588","BK4585","BK4139"],"gpt_icon":0},{"id":"2524756466","title":"Nurix Therapeutics- Receives $15 Mln License Extension Fee From Sanofi","url":"https://stock-news.laohu8.com/highlight/detail?id=2524756466","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524756466?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:04","pubTimestamp":1743591890,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nFWN3QF1D2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NRIX"],"gpt_icon":0},{"id":"2524746621","title":"Nurix Licenses a Drug Discovery Program to Sanofi Targeting a Novel Transcription Factor for Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2524746621","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524746621?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:04","pubTimestamp":1743591890,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nFWN3QF1D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRIX","BK4139"],"gpt_icon":0},{"id":"2524146672","title":"Nurix Therapeutics- Eligible for Additional $465 Mln in Milestones and Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2524146672","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524146672?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:04","pubTimestamp":1743591890,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nFWN3QF1D2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRIX","BK4139"],"gpt_icon":0},{"id":"2524212466","title":"Nurix Licenses a Drug Discovery Program to Sanofi Targeting a Novel Transcription Factor for Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2524212466","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524212466?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:00","pubTimestamp":1743591600,"startTime":"0","endTime":"0","summary":"The undisclosed target is a central regulator of inflammation that is distinct from the previously disclosed STAT6 program. Nurix DEL-AI drug discovery engine generated a drug discovery program to this previously undruggable target. Nurix received a $15 million license extension fee from Sanofi under its 2019 collaboration agreement, bringing the total amount received by Nurix to date to $105 million. Nurix is eligible for an additional $465 million in development, regulatory and commercial milestones for this program as well as potential future royalties and retains an option to co-develop and co-promote in the United States with the parties splitting U.S. profits and losses. Under the collaboration agreement, Nurix is deploying its proprietary DEL-AI drug discovery platform to identify novel agents that use E3 ligases to induce degradation of specified drug targets. Sanofi has the right to license drug candidates resulting from the work, and Nurix has the option to co-develop and co-","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nurix-licenses-drug-discovery-program-110000396.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","SNYNF","BK4007","NRIX"],"gpt_icon":0},{"id":"2522838358","title":"BRIEF-Nurix Therapeutics Announces Multiple Presentations At The American Association For Cancer Research (AACR) 2025 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2522838358","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522838358?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:32","pubTimestamp":1742934759,"startTime":"0","endTime":"0","summary":"BRIEF-Nurix Therapeutics Announces Multiple Presentations At The American Association For Cancer Research (AACR) 2025 Annual MeetingMarch 25 (Reuters) - Nurix Therapeutics Inc NRIX.O:NURIX THERAPEUTIC","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nTUA8XMRCB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRIX","BK4139"],"gpt_icon":0},{"id":"2521624683","title":"Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares May Have Slumped 25% But Getting In Cheap Is Still Unlikely","url":"https://stock-news.laohu8.com/highlight/detail?id=2521624683","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521624683?lang=en_us&edition=fundamental","pubTime":"2025-03-22 21:28","pubTimestamp":1742650106,"startTime":"0","endTime":"0","summary":"Unfortunately for some shareholders, the Nurix Therapeutics, Inc. ( NASDAQ:NRIX ) share price has dived 25% in the last...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nrix/nurix-therapeutics/news/nurix-therapeutics-inc-nasdaqnrix-shares-may-have-slumped-25","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["USJW.SI","LU2095319765.USD","LU2210150020.SGD",".IXIC","MNQmain","BK4139","QID","NDAQ","BK4585","QLD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","TQQQ","BK4112","IE00B64PRP62.GBP","TSYW.SI","LU2210149790.SGD","USAW.SI","SQQQ","NRIX","PSQ","NQmain","IE00BGHQF748.EUR","NVIW.SI","BK4588"],"gpt_icon":1},{"id":"2520486523","title":"Nurix Therapeutics Initiated at Market Perform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2520486523","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520486523?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:32","pubTimestamp":1742214720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NRIX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 17, 2025 08:32 ET (12:32 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRIX","BK4139"],"gpt_icon":0},{"id":"2520540662","title":"Nurix Gets FDA Orphan Designation for Bexobrutideg in Waldenstrom Macroglobulinemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2520540662","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520540662?lang=en_us&edition=fundamental","pubTime":"2025-03-17 19:59","pubTimestamp":1742212740,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics has won a key U.S. Food and Drug Administration designation for its lead asset bexobrutideg in a rare type of non-Hodgkin's lymphoma.Nurix on Monday said the FDA granted orphan-drug designation to bexobrutideg, also known as NX-5948, for the treatment of Waldenstrom macroglobulinemia, a slow growing type of non-Hodgkin's lymphoma characterized by the replacement of normal bone marrow cells by malignant lymphocytic cells.The FDA's orphan-drug program gives special status to drugs and biologics for diseases and disorders that affect fewer than 200,000 people in the U.S. It also provides for an extended marketing exclusivity period against competition.Nurix, a San Francisco clinical-stage biopharmaceutical company, is evaluating bexobrutideg in a Phase 1 study in patients with relapsed or refractory B cell malignancies.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Nurix Gets FDA Orphan Designation for Bexobrutideg in Waldenstrom Macroglobulinemia","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRIX","BK4139"],"gpt_icon":0},{"id":"2520544862","title":"Nurix Therapeutics' Blood Cancer Drug Candidate Gets FDA Orphan Drug Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2520544862","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520544862?lang=en_us&edition=fundamental","pubTime":"2025-03-17 19:25","pubTimestamp":1742210720,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics  said Monday that the US Food and Drug Administration has granted orphan drug designation to the company's experimental drug, bexobrutideq, for treating Waldenstrom macroglobulinemia, a type of blood cancer.The company said the drug is currently being evaluated in a phase 1 trial for adults with relapsed or refractory B-cell malignancies.The US health agency's orphan drug designation program supports the development of treatments for rare diseases, impacting fewer than 200,000 individuals in the US, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NRIX","BK4139"],"gpt_icon":0},{"id":"2520541614","title":"Nurix Therapeutics Inc : Leerink Partners Initiates Coverage With Market Perform Rating; Price Target $16","url":"https://stock-news.laohu8.com/highlight/detail?id=2520541614","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520541614?lang=en_us&edition=fundamental","pubTime":"2025-03-17 19:19","pubTimestamp":1742210394,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nFWN3Q00M0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRIX","BK4139"],"gpt_icon":0},{"id":"2520546096","title":"Nurix Announces U.S. FDA Orphan Drug Designation Granted to Bexobrutideg (Nx-5948) for the Treatment of WaldenstrÖM Macroglobulinemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2520546096","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520546096?lang=en_us&edition=fundamental","pubTime":"2025-03-17 19:00","pubTimestamp":1742209203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nTUA8HG62B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRIX","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":101,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NRIX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-04-08","symbol":"NRIX","fiscalQuarterEnding":"2025/02","expectedEps":-0.72,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1744084800000,"reportTimeType":"post","actualEps":-0.67},{"market":"US","date":"2025-01-28","symbol":"NRIX","fiscalQuarterEnding":"2024/11","expectedEps":-0.67,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1738040400000,"reportTimeType":"post","actualEps":-0.75},{"market":"US","date":"2024-10-11","symbol":"NRIX","fiscalQuarterEnding":"2024/08","expectedEps":-0.67,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1728619200000,"reportTimeType":"post","actualEps":-0.67},{"market":"US","date":"2024-07-11","symbol":"NRIX","fiscalQuarterEnding":"2024/05","expectedEps":-0.66,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1720670400000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2024-04-10","symbol":"NRIX","fiscalQuarterEnding":"2024/02","expectedEps":-0.8,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1712721600000,"reportTimeType":"pre","actualEps":-0.76}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NRIX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NRIX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5556,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":18,"updateTime":1742443200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NRIX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NRIX","date":"2025-04-25","current":-4.214134,"percent":0.650519,"low":-62.292067,"twenty":-20.639588,"median":-6.172754,"eighty":-3.021288,"high":-1.435129,"avg":-12.330553,"sd":13.265447,"marketCap":878234042},"quantilePoints":[{"date":"2020-07-24","current":-33.920716,"twenty":-24.518508,"median":-10.415195,"eighty":-10.415195,"marketCap":704092303},{"date":"2020-07-31","current":-34.598774,"twenty":-34.513124,"median":-33.947481,"eighty":-19.760304,"marketCap":718166742},{"date":"2020-08-07","current":-32.528914,"twenty":-34.277588,"median":-33.777967,"eighty":-31.311979,"marketCap":675202667},{"date":"2020-08-14","current":-42.610558,"twenty":-34.513124,"median":-33.465704,"eighty":-31.311979,"marketCap":884467344},{"date":"2020-08-21","current":-47.927955,"twenty":-46.578978,"median":-33.974247,"eighty":-31.526103,"marketCap":994840572},{"date":"2020-08-28","current":-42.307216,"twenty":-43.77753,"median":-34.491712,"eighty":-32.004312,"marketCap":878170885},{"date":"2020-09-04","current":-45.108664,"twenty":-46.942987,"median":-40.00539,"eighty":-32.528914,"marketCap":936320538},{"date":"2020-09-11","current":-53.191823,"twenty":-48.127804,"median":-41.040319,"eighty":-32.653819,"marketCap":1104102660},{"date":"2020-09-18","current":-61.917351,"twenty":-50.543829,"median":-42.155546,"eighty":-33.278346,"marketCap":1285218461},{"date":"2020-09-25","current":-54.744217,"twenty":-52.563728,"median":-44.555512,"eighty":-33.806517,"marketCap":1136325717},{"date":"2020-10-02","current":-47.223133,"twenty":-53.662894,"median":-45.858096,"eighty":-33.931422,"marketCap":980210564},{"date":"2020-10-09","current":-43.556269,"twenty":-53.124017,"median":-46.072219,"eighty":-34.002797,"marketCap":904097482},{"date":"2020-10-16","current":-26.942667,"twenty":-52.817107,"median":-45.545833,"eighty":-33.806517,"marketCap":992756466},{"date":"2020-10-23","current":-29.863653,"twenty":-52.563728,"median":-45.072977,"eighty":-31.829444,"marketCap":1100386032},{"date":"2020-10-30","current":-26.668495,"twenty":-51.85712,"median":-43.083413,"eighty":-29.943796,"marketCap":982654052},{"date":"2020-11-06","current":-24.45403,"twenty":-50.779366,"median":-42.003875,"eighty":-28.404215,"marketCap":901057630},{"date":"2020-11-13","current":-30.844345,"twenty":-50.672304,"median":-40.968944,"eighty":-28.106844,"marketCap":1136521590},{"date":"2020-11-20","current":-39.691663,"twenty":-50.543829,"median":-39.691663,"eighty":-28.404215,"marketCap":1462518723},{"date":"2020-11-27","current":-41.378876,"twenty":-50.372531,"median":-39.860385,"eighty":-28.513884,"marketCap":1524687426},{"date":"2020-12-04","current":-45.417639,"twenty":-49.48035,"median":-40.858778,"eighty":-28.639005,"marketCap":1673503757},{"date":"2020-12-11","current":-41.885039,"twenty":-48.659544,"median":-41.378876,"eighty":-28.935687,"marketCap":1543338037},{"date":"2020-12-18","current":-37.972816,"twenty":-48.659544,"median":-41.819552,"eighty":-29.346945,"marketCap":1399184358},{"date":"2020-12-24","current":-46.22961,"twenty":-48.274122,"median":-41.944457,"eighty":-29.760311,"marketCap":1703422445},{"date":"2020-12-31","current":-34.672208,"twenty":-48.027879,"median":-41.819552,"eighty":-30.104081,"marketCap":1277566834},{"date":"2021-01-08","current":-42.433383,"twenty":-47.864332,"median":-41.378876,"eighty":-30.504794,"marketCap":1563542865},{"date":"2021-01-15","current":-47.062671,"twenty":-47.777627,"median":-41.944457,"eighty":-30.772639,"marketCap":1734118242},{"date":"2021-01-22","current":-48.560072,"twenty":-47.88554,"median":-42.328119,"eighty":-30.997139,"marketCap":1789292965},{"date":"2021-01-29","current":-38.362984,"twenty":-47.88554,"median":-42.307216,"eighty":-31.311979,"marketCap":1413560870},{"date":"2021-02-05","current":-40.893802,"twenty":-47.792391,"median":-41.832313,"eighty":-31.526103,"marketCap":1506813924},{"date":"2021-02-12","current":-40.735626,"twenty":-47.659522,"median":-41.452691,"eighty":-32.004312,"marketCap":1500985608},{"date":"2021-02-19","current":-33.299947,"twenty":-47.521265,"median":-41.094158,"eighty":-32.00845,"marketCap":1439956323},{"date":"2021-02-26","current":-32.04029,"twenty":-47.452373,"median":-40.916776,"eighty":-31.910725,"marketCap":1385486211},{"date":"2021-03-05","current":-36.669577,"twenty":-47.255049,"median":-40.819987,"eighty":-31.699328,"marketCap":1585665856},{"date":"2021-03-12","current":-44.328731,"twenty":-47.191041,"median":-40.856894,"eighty":-31.910725,"marketCap":1916862967},{"date":"2021-03-19","current":-33.186319,"twenty":-46.996623,"median":-40.893802,"eighty":-32.094275,"marketCap":1435042792},{"date":"2021-03-26","current":-30.581038,"twenty":-46.665613,"median":-40.698718,"eighty":-31.450335,"marketCap":1322385262},{"date":"2021-04-01","current":-31.800591,"twenty":-46.398331,"median":-40.255825,"eighty":-31.299135,"marketCap":1375121135},{"date":"2021-04-09","current":-29.843158,"twenty":-46.398331,"median":-39.860385,"eighty":-31.299135,"marketCap":1290477843},{"date":"2021-04-16","current":-23.353884,"twenty":-46.303426,"median":-39.544033,"eighty":-30.581038,"marketCap":1287406212},{"date":"2021-04-23","current":-24.632998,"twenty":-46.250655,"median":-39.239359,"eighty":-29.863653,"marketCap":1357918643},{"date":"2021-04-30","current":-28.011789,"twenty":-46.22961,"median":-38.293228,"eighty":-29.233053,"marketCap":1544177895},{"date":"2021-05-07","current":-21.672533,"twenty":-46.214968,"median":-37.972816,"eighty":-28.513884,"marketCap":1194720060},{"date":"2021-05-14","current":-20.876104,"twenty":-46.135608,"median":-37.392837,"eighty":-28.035923,"marketCap":1150816093},{"date":"2021-05-21","current":-19.975093,"twenty":-46.072219,"median":-36.781282,"eighty":-27.733548,"marketCap":1101146960},{"date":"2021-05-28","current":-22.444828,"twenty":-46.071434,"median":-36.217061,"eighty":-27.279718,"marketCap":1237293603},{"date":"2021-06-04","current":-23.619361,"twenty":-46.054562,"median":-35.855252,"eighty":-26.908051,"marketCap":1302040867},{"date":"2021-06-11","current":-23.289526,"twenty":-46.025019,"median":-35.178371,"eighty":-26.485011,"marketCap":1283858416},{"date":"2021-06-18","current":-23.281481,"twenty":-45.9006,"median":-34.635491,"eighty":-26.018513,"marketCap":1283414942},{"date":"2021-06-25","current":-23.740032,"twenty":-45.803589,"median":-34.38465,"eighty":-25.363461,"marketCap":1308692983},{"date":"2021-07-02","current":-20.66694,"twenty":-45.658247,"median":-34.045621,"eighty":-24.735971,"marketCap":1139285759},{"date":"2021-07-09","current":-19.910735,"twenty":-45.570441,"median":-33.905983,"eighty":-24.275811,"marketCap":1097599164},{"date":"2021-07-16","current":-12.955838,"twenty":-45.492648,"median":-33.777967,"eighty":-23.955631,"marketCap":1154209718},{"date":"2021-07-23","current":-15.319606,"twenty":-45.443125,"median":-33.4709,"eighty":-23.759339,"marketCap":1364793016},{"date":"2021-07-30","current":-15.329579,"twenty":-45.421857,"median":-33.153441,"eighty":-23.648322,"marketCap":1365681553},{"date":"2021-08-06","current":-15.135092,"twenty":-45.360696,"median":-32.598138,"eighty":-23.328141,"marketCap":1348355079},{"date":"2021-08-13","current":-15.354513,"twenty":-45.194292,"median":-32.528914,"eighty":-22.834194,"marketCap":1367902896},{"date":"2021-08-20","current":-15.718554,"twenty":-45.087252,"median":-32.175253,"eighty":-22.132692,"marketCap":1400334501},{"date":"2021-08-27","current":-16.032725,"twenty":-45.014038,"median":-31.862081,"eighty":-21.357179,"marketCap":1428323420},{"date":"2021-09-03","current":-16.53141,"twenty":-44.955765,"median":-31.572219,"eighty":-21.011255,"marketCap":1472750276},{"date":"2021-09-10","current":-17.852926,"twenty":-44.788071,"median":-31.369794,"eighty":-20.76026,"marketCap":1590481444},{"date":"2021-09-17","current":-17.952663,"twenty":-44.496922,"median":-30.844345,"eighty":-20.333888,"marketCap":1599366816},{"date":"2021-09-24","current":-16.381805,"twenty":-44.376914,"median":-30.422702,"eighty":-19.559984,"marketCap":1459422219},{"date":"2021-10-01","current":-15.578922,"twenty":-44.316685,"median":-29.884151,"eighty":-19.127177,"marketCap":1387894981},{"date":"2021-10-08","current":-13.743761,"twenty":-44.117739,"median":-29.610086,"eighty":-17.952663,"marketCap":1224404151},{"date":"2021-10-15","current":-12.938682,"twenty":-43.730361,"median":-29.233053,"eighty":-17.668412,"marketCap":1286182613},{"date":"2021-10-22","current":-12.588624,"twenty":-43.528918,"median":-28.787346,"eighty":-17.308361,"marketCap":1251384748},{"date":"2021-10-29","current":-15.012102,"twenty":-43.390876,"median":-28.448284,"eighty":-16.700963,"marketCap":1492293042},{"date":"2021-11-05","current":-15.258938,"twenty":-43.173648,"median":-28.037639,"eighty":-16.366844,"marketCap":1516829998},{"date":"2021-11-12","current":-15.285866,"twenty":-42.883876,"median":-27.98663,"eighty":-16.040704,"marketCap":1519506756},{"date":"2021-11-19","current":-14.065151,"twenty":-42.564996,"median":-27.691781,"eighty":-15.874144,"marketCap":1398160356},{"date":"2021-11-26","current":-13.490696,"twenty":-42.483999,"median":-27.43862,"eighty":-15.694616,"marketCap":1341056168},{"date":"2021-12-03","current":-12.130856,"twenty":-42.416511,"median":-27.118823,"eighty":-15.489486,"marketCap":1205879848},{"date":"2021-12-10","current":-12.817508,"twenty":-42.340661,"median":-26.905637,"eighty":-15.364487,"marketCap":1274137198},{"date":"2021-12-17","current":-12.68287,"twenty":-42.246548,"median":-26.61577,"eighty":-15.315616,"marketCap":1260753404},{"date":"2021-12-23","current":-13.697141,"twenty":-42.003875,"median":-26.468139,"eighty":-15.285866,"marketCap":1361577986},{"date":"2021-12-31","current":-12.992537,"twenty":-41.885039,"median":-26.220076,"eighty":-15.258938,"marketCap":1291536130},{"date":"2022-01-07","current":-12.413595,"twenty":-41.779588,"median":-25.687803,"eighty":-15.182643,"marketCap":1233985816},{"date":"2022-01-14","current":-10.429933,"twenty":-41.754064,"median":-25.276578,"eighty":-15.030368,"marketCap":1036797916},{"date":"2022-01-21","current":-8.576421,"twenty":-41.512966,"median":-24.914563,"eighty":-15.007614,"marketCap":852547684},{"date":"2022-01-28","current":-6.741548,"twenty":-41.393639,"median":-24.632998,"eighty":-14.872977,"marketCap":790068982},{"date":"2022-02-04","current":-6.947688,"twenty":-41.151102,"median":-24.250872,"eighty":-14.737142,"marketCap":814227377},{"date":"2022-02-11","current":-6.711009,"twenty":-41.051087,"median":-24.085956,"eighty":-14.377091,"marketCap":786489961},{"date":"2022-02-18","current":-6.03151,"twenty":-41.028992,"median":-23.832546,"eighty":-14.101054,"marketCap":706856734},{"date":"2022-02-25","current":-6.073501,"twenty":-40.972053,"median":-23.780255,"eighty":-13.87217,"marketCap":711777888},{"date":"2022-03-04","current":-5.241305,"twenty":-40.912935,"median":-23.683718,"eighty":-13.606485,"marketCap":614249554},{"date":"2022-03-11","current":-5.252758,"twenty":-40.895309,"median":-23.643495,"eighty":-13.42607,"marketCap":615591687},{"date":"2022-03-18","current":-5.565785,"twenty":-40.849513,"median":-23.506734,"eighty":-13.123967,"marketCap":652276657},{"date":"2022-03-25","current":-5.323828,"twenty":-40.76937,"median":-23.285503,"eighty":-12.977278,"marketCap":623920753},{"date":"2022-04-01","current":-5.339138,"twenty":-40.691336,"median":-22.991871,"eighty":-12.936887,"marketCap":625714918},{"date":"2022-04-08","current":-4.918066,"twenty":-40.453018,"median":-22.384493,"eighty":-12.779809,"marketCap":666161875},{"date":"2022-04-14","current":-4.54639,"twenty":-40.267425,"median":-22.114994,"eighty":-12.717876,"marketCap":615817657},{"date":"2022-04-22","current":-4.164759,"twenty":-40.120852,"median":-21.672533,"eighty":-12.645172,"marketCap":564124934},{"date":"2022-04-29","current":-3.673616,"twenty":-39.947388,"median":-21.294431,"eighty":-12.566184,"marketCap":497598647},{"date":"2022-05-06","current":-3.172518,"twenty":-39.792896,"median":-21.053088,"eighty":-12.38936,"marketCap":429723854},{"date":"2022-05-13","current":-3.179155,"twenty":-39.645265,"median":-20.827835,"eighty":-11.806013,"marketCap":430622858},{"date":"2022-05-20","current":-3.311896,"twenty":-39.55036,"median":-20.66694,"eighty":-10.865261,"marketCap":448602936},{"date":"2022-05-27","current":-2.993317,"twenty":-39.465999,"median":-20.349173,"eighty":-10.415195,"marketCap":405450749},{"date":"2022-06-03","current":-3.507689,"twenty":-39.364993,"median":-19.942914,"eighty":-8.82954,"marketCap":475123550},{"date":"2022-06-10","current":-3.358355,"twenty":-39.064084,"median":-19.476319,"eighty":-8.497433,"marketCap":454895963},{"date":"2022-06-17","current":-3.690209,"twenty":-38.354548,"median":-19.267156,"eighty":-7.256135,"marketCap":499846157},{"date":"2022-06-24","current":-4.204581,"twenty":-38.320804,"median":-18.673351,"eighty":-7.10802,"marketCap":569518957},{"date":"2022-07-01","current":-4.420286,"twenty":-38.265652,"median":-17.952663,"eighty":-6.733913,"marketCap":598736584},{"date":"2022-07-08","current":-5.39332,"twenty":-38.12418,"median":-17.852926,"eighty":-6.517586,"marketCap":833111606},{"date":"2022-07-15","current":-5.033969,"twenty":-37.996015,"median":-17.690853,"eighty":-6.131526,"marketCap":777602193},{"date":"2022-07-22","current":-4.817749,"twenty":-37.96438,"median":-17.424057,"eighty":-5.923095,"marketCap":744202462},{"date":"2022-07-29","current":-4.860384,"twenty":-37.641701,"median":-17.192168,"eighty":-5.690631,"marketCap":750788325},{"date":"2022-08-05","current":-5.901894,"twenty":-37.291604,"median":-16.760805,"eighty":-5.594034,"marketCap":911671537},{"date":"2022-08-12","current":-5.094876,"twenty":-36.98928,"median":-16.51645,"eighty":-5.581055,"marketCap":787010568},{"date":"2022-08-19","current":-4.753796,"twenty":-36.81114,"median":-16.35687,"eighty":-5.500216,"marketCap":734323668},{"date":"2022-08-26","current":-4.69898,"twenty":-36.691918,"median":-16.062646,"eighty":-5.391929,"marketCap":725856131},{"date":"2022-09-02","current":-4.881701,"twenty":-36.455195,"median":-15.987844,"eighty":-5.336076,"marketCap":754081256},{"date":"2022-09-09","current":-4.832975,"twenty":-36.180153,"median":-15.913041,"eighty":-5.274732,"marketCap":746554556},{"date":"2022-09-16","current":-4.73857,"twenty":-35.969349,"median":-15.745981,"eighty":-5.241204,"marketCap":731971575},{"date":"2022-09-23","current":-3.815828,"twenty":-35.840856,"median":-15.578922,"eighty":-5.1771,"marketCap":589434693},{"date":"2022-09-30","current":-3.968095,"twenty":-35.464759,"median":-15.498714,"eighty":-5.129711,"marketCap":612955631},{"date":"2022-10-07","current":-3.018537,"twenty":-35.207989,"median":-15.393576,"eighty":-5.038841,"marketCap":517211157},{"date":"2022-10-14","current":-2.99102,"twenty":-35.023324,"median":-15.357007,"eighty":-4.976716,"marketCap":512496379},{"date":"2022-10-21","current":-3.128602,"twenty":-34.771308,"median":-15.319606,"eighty":-4.938445,"marketCap":536070269},{"date":"2022-10-28","current":-3.53034,"twenty":-34.628148,"median":-15.302152,"eighty":-4.900583,"marketCap":604906030},{"date":"2022-11-04","current":-3.566111,"twenty":-34.512456,"median":-15.279711,"eighty":-4.868911,"marketCap":611035241},{"date":"2022-11-11","current":-4.014626,"twenty":-34.412754,"median":-15.258938,"eighty":-4.845766,"marketCap":687886124},{"date":"2022-11-18","current":-3.577117,"twenty":-34.361046,"median":-15.249962,"eighty":-4.812267,"marketCap":612921153},{"date":"2022-11-25","current":-3.263432,"twenty":-34.253984,"median":-15.182643,"eighty":-4.789322,"marketCap":559172682},{"date":"2022-12-02","current":-3.469804,"twenty":-34.059896,"median":-15.127612,"eighty":-4.722125,"marketCap":594533518},{"date":"2022-12-09","current":-3.282693,"twenty":-33.952835,"median":-15.025566,"eighty":-4.692889,"marketCap":562473027},{"date":"2022-12-16","current":-3.348732,"twenty":-33.90893,"median":-15.000882,"eighty":-4.580903,"marketCap":573788494},{"date":"2022-12-23","current":-2.856191,"twenty":-33.866191,"median":-14.922344,"eighty":-4.442852,"marketCap":489393966},{"date":"2022-12-30","current":-3.021288,"twenty":-33.818475,"median":-14.837073,"eighty":-4.382565,"marketCap":517682635},{"date":"2023-01-06","current":-3.015785,"twenty":-33.777967,"median":-14.77873,"eighty":-4.217856,"marketCap":516739679},{"date":"2023-01-13","current":-3.208399,"twenty":-33.702061,"median":-14.683782,"eighty":-4.196497,"marketCap":549743126},{"date":"2023-01-20","current":-3.491817,"twenty":-33.653895,"median":-14.446907,"eighty":-4.128919,"marketCap":598305340},{"date":"2023-01-27","current":-3.406516,"twenty":-33.368328,"median":-14.352156,"eighty":-4.010192,"marketCap":583689528},{"date":"2023-02-03","current":-3.445039,"twenty":-33.209045,"median":-14.087591,"eighty":-3.965659,"marketCap":590290218},{"date":"2023-02-10","current":-3.053513,"twenty":-33.160017,"median":-13.935001,"eighty":-3.919014,"marketCap":550731591},{"date":"2023-02-17","current":-2.547652,"twenty":-32.807783,"median":-13.720451,"eighty":-3.897949,"marketCap":459494512},{"date":"2023-02-24","current":-2.309137,"twenty":-32.658227,"median":-13.602895,"eighty":-3.855472,"marketCap":416475993},{"date":"2023-03-03","current":-2.377284,"twenty":-32.594539,"median":-13.490696,"eighty":-3.800691,"marketCap":428766998},{"date":"2023-03-10","current":-2.243611,"twenty":-32.579736,"median":-13.344839,"eighty":-3.741978,"marketCap":404657718},{"date":"2023-03-17","current":-2.361558,"twenty":-32.549134,"median":-13.149614,"eighty":-3.642714,"marketCap":425930612},{"date":"2023-03-24","current":-2.325443,"twenty":-32.528914,"median":-12.994781,"eighty":-3.58207,"marketCap":419416929},{"date":"2023-03-31","current":-2.335966,"twenty":-32.397695,"median":-12.961122,"eighty":-3.523935,"marketCap":421314743},{"date":"2023-04-06","current":-2.30966,"twenty":-32.202246,"median":-12.94317,"eighty":-3.504769,"marketCap":416570208},{"date":"2023-04-14","current":-2.691652,"twenty":-32.04029,"median":-12.936438,"eighty":-3.48081,"marketCap":480621436},{"date":"2023-04-21","current":-2.888278,"twenty":-31.878334,"median":-12.817508,"eighty":-3.469804,"marketCap":515730997},{"date":"2023-04-28","current":-2.55614,"twenty":-31.865332,"median":-12.763653,"eighty":-3.447373,"marketCap":456424305},{"date":"2023-05-05","current":-2.508312,"twenty":-31.812889,"median":-12.718774,"eighty":-3.428529,"marketCap":447884141},{"date":"2023-05-12","current":-2.704938,"twenty":-31.68378,"median":-12.664919,"eighty":-3.405415,"marketCap":482993703},{"date":"2023-05-19","current":-2.588025,"twenty":-31.522804,"median":-12.626771,"eighty":-3.394959,"marketCap":462117747},{"date":"2023-05-26","current":-2.585368,"twenty":-31.450335,"median":-12.566184,"eighty":-3.361663,"marketCap":461643294},{"date":"2023-06-01","current":-2.688995,"twenty":-31.383926,"median":-12.512329,"eighty":-3.356987,"marketCap":480146982},{"date":"2023-06-09","current":-2.880307,"twenty":-31.270013,"median":-12.413595,"eighty":-3.348533,"marketCap":514307637},{"date":"2023-06-16","current":-2.952049,"twenty":-31.073536,"median":-12.198175,"eighty":-3.328882,"marketCap":527117882},{"date":"2023-06-23","current":-2.707595,"twenty":-30.808492,"median":-11.815274,"eighty":-3.31376,"marketCap":483468157},{"date":"2023-06-30","current":-2.65711,"twenty":-30.665079,"median":-11.454796,"eighty":-3.301954,"marketCap":474453540},{"date":"2023-07-05","current":-2.673053,"twenty":-30.631463,"median":-11.175982,"eighty":-3.28641,"marketCap":477300261},{"date":"2023-07-13","current":-2.651796,"twenty":-30.517704,"median":-10.600474,"eighty":-3.272787,"marketCap":473504632},{"date":"2023-07-21","current":-2.962065,"twenty":-30.3277,"median":-10.429933,"eighty":-3.261231,"marketCap":466335686},{"date":"2023-07-28","current":-2.819702,"twenty":-30.147641,"median":-10.415195,"eighty":-3.239766,"marketCap":443922653},{"date":"2023-08-04","current":-2.844195,"twenty":-29.958421,"median":-8.865892,"eighty":-3.207321,"marketCap":447778659},{"date":"2023-08-11","current":-2.887057,"twenty":-29.871852,"median":-8.746962,"eighty":-3.177645,"marketCap":454526669},{"date":"2023-08-18","current":-2.614577,"twenty":-29.851356,"median":-8.394659,"eighty":-3.162187,"marketCap":411628606},{"date":"2023-08-25","current":-2.571715,"twenty":-29.563472,"median":-7.329429,"eighty":-3.113743,"marketCap":404880596},{"date":"2023-09-01","current":-2.602331,"twenty":-29.358973,"median":-7.18055,"eighty":-3.092962,"marketCap":409700603},{"date":"2023-09-08","current":-2.749286,"twenty":-29.301388,"median":-7.085115,"eighty":-3.067123,"marketCap":432836637},{"date":"2023-09-15","current":-2.718671,"twenty":-29.149148,"median":-6.741548,"eighty":-3.032295,"marketCap":428016630},{"date":"2023-09-22","current":-2.767656,"twenty":-28.988249,"median":-6.711009,"eighty":-3.021288,"marketCap":435728641},{"date":"2023-09-29","current":-2.492115,"twenty":-28.817014,"median":-6.260554,"eighty":-3.017343,"marketCap":392348577},{"date":"2023-10-06","current":-2.106357,"twenty":-28.588957,"median":-6.159393,"eighty":-3.010282,"marketCap":331616488},{"date":"2023-10-13","current":-2.032012,"twenty":-28.487644,"median":-6.073501,"eighty":-2.985517,"marketCap":302178474},{"date":"2023-10-20","current":-1.554179,"twenty":-28.433987,"median":-6.03151,"eighty":-2.97759,"marketCap":231120454},{"date":"2023-10-27","current":-1.441652,"twenty":-28.405392,"median":-5.928439,"eighty":-2.968495,"marketCap":214386654},{"date":"2023-10-31","current":-1.715631,"twenty":-28.376798,"median":-5.901894,"eighty":-2.952049,"marketCap":255129819},{"date":"2023-11-10","current":-1.722155,"twenty":-28.039355,"median":-5.858721,"eighty":-2.930485,"marketCap":256099895},{"date":"2023-11-17","current":-1.979826,"twenty":-28.035923,"median":-5.71039,"eighty":-2.91485,"marketCap":294417871},{"date":"2023-11-24","current":-2.02875,"twenty":-28.016616,"median":-5.633903,"eighty":-2.901331,"marketCap":301693436},{"date":"2023-11-30","current":-1.999395,"twenty":-28.001725,"median":-5.60396,"eighty":-2.893345,"marketCap":297328097},{"date":"2023-12-08","current":-2.788716,"twenty":-27.97095,"median":-5.565785,"eighty":-2.885679,"marketCap":414707216},{"date":"2023-12-15","current":-2.915921,"twenty":-27.861878,"median":-5.524342,"eighty":-2.86541,"marketCap":433623685},{"date":"2023-12-22","current":-3.000724,"twenty":-27.700134,"median":-5.423339,"eighty":-2.87393,"marketCap":446234665},{"date":"2023-12-29","current":-3.493234,"twenty":-27.650014,"median":-5.393661,"eighty":-2.880307,"marketCap":519475355},{"date":"2024-01-05","current":-3.212732,"twenty":-27.611556,"median":-5.386367,"eighty":-2.883495,"marketCap":477762114},{"date":"2024-01-12","current":-3.049649,"twenty":-27.40916,"median":-5.341757,"eighty":-2.885708,"marketCap":453510230},{"date":"2024-01-19","current":-2.671297,"twenty":-27.28668,"median":-5.318832,"eighty":-2.87393,"marketCap":397245859},{"date":"2024-01-26","current":-2.641942,"twenty":-27.21536,"median":-5.252758,"eighty":-2.857516,"marketCap":392880520},{"date":"2024-02-02","current":-2.65825,"twenty":-27.048361,"median":-5.24238,"eighty":-2.840818,"marketCap":395305709},{"date":"2024-02-09","current":-2.811548,"twenty":-26.929464,"median":-5.238007,"eighty":-2.82109,"marketCap":418102480},{"date":"2024-02-16","current":-3.345699,"twenty":-26.906442,"median":-5.1771,"eighty":-2.824233,"marketCap":481606727},{"date":"2024-02-23","current":-3.583465,"twenty":-26.854991,"median":-5.166441,"eighty":-2.82705,"marketCap":515832586},{"date":"2024-03-01","current":-4.194862,"twenty":-26.65795,"median":-5.128375,"eighty":-2.833277,"marketCap":603841937},{"date":"2024-03-08","current":-4.925141,"twenty":-26.590462,"median":-5.082199,"eighty":-2.839703,"marketCap":708964218},{"date":"2024-03-15","current":-4.768895,"twenty":-26.485011,"median":-5.040059,"eighty":-2.844164,"marketCap":686472939},{"date":"2024-03-22","current":-4.422437,"twenty":-26.463921,"median":-5.012652,"eighty":-2.84417,"marketCap":636600973},{"date":"2024-03-28","current":-4.964658,"twenty":-26.447049,"median":-4.974951,"eighty":-2.844195,"marketCap":714652544},{"date":"2024-04-05","current":-4.759789,"twenty":-26.415414,"median":-4.98173,"eighty":-2.85338,"marketCap":685162068},{"date":"2024-04-12","current":-5.844453,"twenty":-26.024738,"median":-4.983486,"eighty":-2.856191,"marketCap":845885164},{"date":"2024-04-19","current":-5.918098,"twenty":-25.993611,"median":-5.019289,"eighty":-2.859503,"marketCap":856544136},{"date":"2024-04-26","current":-5.06563,"twenty":-25.687803,"median":-5.038537,"eighty":-2.861707,"marketCap":733163817},{"date":"2024-05-03","current":-5.217271,"twenty":-25.638591,"median":-5.044024,"eighty":-2.862564,"marketCap":755111278},{"date":"2024-05-10","current":-5.717277,"twenty":-25.421383,"median":-5.067576,"eighty":-2.869679,"marketCap":827478580},{"date":"2024-05-17","current":-6.311545,"twenty":-25.131772,"median":-5.094876,"eighty":-2.880307,"marketCap":913488899},{"date":"2024-05-24","current":-6.217282,"twenty":-24.930653,"median":-5.129488,"eighty":-2.885621,"marketCap":899845883},{"date":"2024-05-31","current":-6.385317,"twenty":-24.90491,"median":-5.166441,"eighty":-2.885737,"marketCap":924166042},{"date":"2024-06-07","current":-6.692697,"twenty":-24.789066,"median":-5.1771,"eighty":-2.886406,"marketCap":968654138},{"date":"2024-06-14","current":-7.439111,"twenty":-24.684484,"median":-5.217271,"eighty":-2.886861,"marketCap":1076684830},{"date":"2024-06-21","current":-9.324456,"twenty":-24.561411,"median":-5.238007,"eighty":-2.887545,"marketCap":1349556538},{"date":"2024-06-28","current":-9.222185,"twenty":-24.489824,"median":-5.241053,"eighty":-2.888034,"marketCap":1334754535},{"date":"2024-07-05","current":-8.630791,"twenty":-24.406952,"median":-5.243454,"eighty":-2.891219,"marketCap":1249160344},{"date":"2024-07-12","current":-8.599856,"twenty":-24.225934,"median":-5.27107,"eighty":-2.893428,"marketCap":1418993496},{"date":"2024-07-15","current":-9.298619,"twenty":-24.176056,"median":-5.289382,"eighty":-2.89351,"marketCap":1534290743},{"date":"2024-08-02","current":-8.381249,"twenty":-24.126179,"median":-5.301609,"eighty":-2.893593,"marketCap":1382922848},{"date":"2024-08-09","current":-7.869864,"twenty":-24.095497,"median":-5.323828,"eighty":-2.900398,"marketCap":1298543299},{"date":"2024-08-16","current":-8.650604,"twenty":-24.085956,"median":-5.341757,"eighty":-2.901564,"marketCap":1427367039},{"date":"2024-08-23","current":-9.009745,"twenty":-24.013553,"median":-5.362102,"eighty":-2.908488,"marketCap":1486625959},{"date":"2024-08-30","current":-9.759256,"twenty":-23.868747,"median":-5.393661,"eighty":-2.913975,"marketCap":1610296750},{"date":"2024-09-06","current":-9.540649,"twenty":-23.810825,"median":-5.420716,"eighty":-2.914675,"marketCap":1574226102},{"date":"2024-09-13","current":-9.201027,"twenty":-23.789909,"median":-5.51818,"eighty":-2.91485,"marketCap":1518187775},{"date":"2024-09-20","current":-9.782678,"twenty":-23.775429,"median":-5.543294,"eighty":-2.915707,"marketCap":1614161462},{"date":"2024-09-27","current":-9.060493,"twenty":-23.746468,"median":-5.565785,"eighty":-2.919431,"marketCap":1494999502},{"date":"2024-10-04","current":-8.459323,"twenty":-23.694981,"median":-5.590599,"eighty":-2.925547,"marketCap":1395805222},{"date":"2024-10-11","current":-8.533493,"twenty":-23.677283,"median":-5.633903,"eighty":-2.929759,"marketCap":1408043478},{"date":"2024-10-18","current":-9.894409,"twenty":-23.669238,"median":-5.701078,"eighty":-2.93449,"marketCap":1751072891},{"date":"2024-10-25","current":-10.094538,"twenty":-23.629015,"median":-5.717277,"eighty":-2.941841,"marketCap":1786491032},{"date":"2024-10-31","current":-9.63424,"twenty":-23.600054,"median":-5.770556,"eighty":-2.946344,"marketCap":1705029307},{"date":"2024-11-08","current":-10.903062,"twenty":-23.538913,"median":-5.797195,"eighty":-2.950125,"marketCap":1929580321},{"date":"2024-11-15","current":-10.750964,"twenty":-23.415024,"median":-5.852091,"eighty":-2.951769,"marketCap":1902662534},{"date":"2024-11-22","current":-8.9538,"twenty":-23.315269,"median":-5.901806,"eighty":-2.95777,"marketCap":1584607628},{"date":"2024-11-29","current":-8.849732,"twenty":-23.286308,"median":-5.923268,"eighty":-2.961776,"marketCap":1566190195},{"date":"2024-12-06","current":-8.029201,"twenty":-23.255738,"median":-6.004165,"eighty":-2.966351,"marketCap":1420975816},{"date":"2024-12-13","current":-8.22933,"twenty":-23.127022,"median":-6.053173,"eighty":-2.974573,"marketCap":1456393957},{"date":"2024-12-20","current":-8.021195,"twenty":-22.834194,"median":-6.127117,"eighty":-2.977919,"marketCap":1419559091},{"date":"2024-12-27","current":-7.977167,"twenty":-22.567108,"median":-6.172754,"eighty":-2.979516,"marketCap":1411767100},{"date":"2025-01-03","current":-7.809058,"twenty":-22.444828,"median":-6.217282,"eighty":-2.981965,"marketCap":1382015861},{"date":"2025-01-10","current":-7.809058,"twenty":-22.348291,"median":-6.23765,"eighty":-2.984807,"marketCap":1382015861},{"date":"2025-01-17","current":-7.801053,"twenty":-22.22762,"median":-6.295151,"eighty":-2.985517,"marketCap":1380599136},{"date":"2025-01-24","current":-7.989175,"twenty":-22.097296,"median":-6.352529,"eighty":-2.988819,"marketCap":1413892188},{"date":"2025-01-31","current":-7.846683,"twenty":-21.901004,"median":-6.426301,"eighty":-2.992398,"marketCap":1518874642},{"date":"2025-02-07","current":-7.464444,"twenty":-21.730455,"median":-6.524662,"eighty":-2.997761,"marketCap":1444884995},{"date":"2025-02-14","current":-6.888145,"twenty":-21.489113,"median":-6.577942,"eighty":-3.002681,"marketCap":1333331374},{"date":"2025-02-21","current":-6.680364,"twenty":-21.357179,"median":-6.581844,"eighty":-3.006504,"marketCap":1293111361},{"date":"2025-02-28","current":-5.880602,"twenty":-21.304084,"median":-6.592188,"eighty":-3.010282,"marketCap":1138302255},{"date":"2025-03-07","current":-5.508164,"twenty":-21.23329,"median":-6.558831,"eighty":-3.010371,"marketCap":1066209778},{"date":"2025-03-14","current":-5.171009,"twenty":-21.149625,"median":-6.524662,"eighty":-3.012617,"marketCap":1000947116},{"date":"2025-03-21","current":-5.437597,"twenty":-21.011255,"median":-6.45499,"eighty":-3.01609,"marketCap":1052550151},{"date":"2025-03-28","current":-4.920104,"twenty":-20.919545,"median":-6.37712,"eighty":-3.017343,"marketCap":952379553},{"date":"2025-04-04","current":-4.120342,"twenty":-20.837489,"median":-6.311545,"eighty":-3.018537,"marketCap":797570446},{"date":"2025-04-11","current":-3.222789,"twenty":-20.766695,"median":-6.249102,"eighty":-3.018604,"marketCap":671635583},{"date":"2025-04-17","current":-3.584941,"twenty":-20.731298,"median":-6.217282,"eighty":-3.019221,"marketCap":747108821},{"date":"2025-04-25","current":-4.214134,"twenty":-20.639588,"median":-6.172754,"eighty":-3.021288,"marketCap":878234042}],"updateTime":1745911281402}}}